サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1371130

世界の標的放射線治療薬市場：考察と予測 (2029年まで)

Global Targeted Radiotherapy Drug Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 97 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の標的放射線治療薬市場：考察と予測 (2029年まで)
出版日: 2023年10月31日
発行: QYResearch
ページ情報: 英文 97 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、標的放射線治療薬 (Targeted Radiotherapy Drug) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の標的放射線治療薬の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Radioactive Iodine Therapeutic Drugs
    • Radioactive Antibody Therapeutic Drugs
    • Others
  • 市場：用途別
    • 世界の標的放射線治療薬の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • General Hospital
    • Specialty Hospital
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の標的放射線治療薬の市場展望 (2018-2029)
  • 世界の標的放射線治療薬の市場成長トレンド：地域別
    • 標的放射線治療薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • 標的放射線治療薬の市場規模実績：地域別 (2018-2023)
    • 標的放射線治療薬の市場規模予測：地域別 (2024-2029)
  • 標的放射線治療薬 市場動向
    • 標的放射線治療薬 業界動向
    • 標的放射線治療薬 市場の促進要因
    • 標的放射線治療薬 市場の課題
    • 標的放射線治療薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 標的放射線治療薬 ：競合別
    • 世界の標的放射線治療薬の収益：企業別 (2018-2023)
    • 世界の標的放射線治療薬の収益シェア：企業別 (2018-2023)
  • 世界の標的放射線治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 標的放射線治療薬, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の標的放射線治療薬 市場集中度
    • 世界の標的放射線治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 標的放射線治療薬の収益 2022
  • 世界の主要企業 標的放射線治療薬 本社 および提供地域
  • 世界の主要企業 標的放射線治療薬, 製品およびアプリケーション
  • 世界の主要企業 標的放射線治療薬, 業界参入時期
  • M&A, 拡張計画

第4章 標的放射線治療薬 内訳データ：タイプ別

  • 世界の標的放射線治療薬の市場規模実績：タイプ別 (2018-2023)
  • 世界の標的放射線治療薬の市場規模予測：タイプ別 (2024-2029)

第5章 標的放射線治療薬 内訳データ：用途別

  • 世界の標的放射線治療薬の市場規模実績：用途別 (2018-2023)
  • 世界の標的放射線治療薬の市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の標的放射線治療薬 市場規模 (2018-2029)
  • 北米の標的放射線治療薬 市場規模：タイプ別
    • 北米の標的放射線治療薬 市場規模：タイプ別 (2018-2023)
    • 北米の標的放射線治療薬 市場規模：タイプ別 (2024-2029)
    • 北米の標的放射線治療薬の市場シェア：タイプ別 (2018-2029)
  • 北米の標的放射線治療薬 市場規模：用途別
    • 北米の標的放射線治療薬 市場規模：用途別 (2018-2023)
    • 北米の標的放射線治療薬 市場規模：用途別 (2024-2029)
    • 北米の標的放射線治療薬の市場シェア：用途別 (2018-2029)
  • 北米の標的放射線治療薬 市場規模：国別
    • 北米の標的放射線治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の標的放射線治療薬 市場規模：国別 (2018-2023)
    • 北米の標的放射線治療薬 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の標的放射線治療薬 市場規模 (2018-2029)
  • 欧州の標的放射線治療薬 市場規模：タイプ別
    • 欧州の標的放射線治療薬 市場規模：タイプ別 (2018-2023)
    • 欧州の標的放射線治療薬 市場規模：タイプ別 (2024-2029)
    • 欧州の標的放射線治療薬の市場シェア：タイプ別 (2018-2029)
  • 欧州の標的放射線治療薬 市場規模：用途別
    • 欧州の標的放射線治療薬 市場規模：用途別 (2018-2023)
    • 欧州の標的放射線治療薬 市場規模：用途別 (2024-2029)
    • 欧州の標的放射線治療薬の市場シェア：用途別 (2018-2029)
  • 欧州の標的放射線治療薬 市場規模：国別
    • 欧州の標的放射線治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の標的放射線治療薬 市場規模：国別 (2018-2023)
    • 欧州の標的放射線治療薬 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の標的放射線治療薬 市場規模 (2018-2029)
  • 中国の標的放射線治療薬 市場規模：タイプ別
    • 中国の標的放射線治療薬 市場規模：タイプ別 (2018-2023)
    • 中国の標的放射線治療薬 市場規模：タイプ別 (2024-2029)
    • 中国の標的放射線治療薬の市場シェア：タイプ別 (2018-2029)
  • 中国の標的放射線治療薬 市場規模：用途別
    • 中国の標的放射線治療薬 市場規模：用途別 (2018-2023)
    • 中国の標的放射線治療薬 市場規模：用途別 (2024-2029)
    • 中国の標的放射線治療薬の市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 標的放射線治療薬 市場規模 (2018-2029)
  • アジア地域 標的放射線治療薬 市場規模：タイプ別
    • アジア地域 標的放射線治療薬 市場規模：タイプ別 (2018-2023)
    • アジア地域 標的放射線治療薬 市場規模：タイプ別 (2024-2029)
    • アジア地域 標的放射線治療薬の市場シェア：タイプ別 (2018-2029)
  • アジア地域 標的放射線治療薬 市場規模：用途別
    • アジア地域 標的放射線治療薬 市場規模：用途別 (2018-2023)
    • アジア地域 標的放射線治療薬 市場規模：用途別 (2024-2029)
    • アジア地域 標的放射線治療薬の市場シェア：用途別 (2018-2029)
  • アジア地域 標的放射線治療薬 市場規模：地域別
    • アジア地域 標的放射線治療薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 標的放射線治療薬 市場規模：地域別 (2018-2023)
    • アジア地域 標的放射線治療薬 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：タイプ別
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 標的放射線治療薬の市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：用途別
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 標的放射線治療薬の市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：国別
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 標的放射線治療薬 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Novartis
  • Bayer
  • Endocyte
  • Progenics Pharmaceuticals
  • Jubilant Radiopharma
  • Curium
  • Fermi Energia
  • Nucleus RadioPharma

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Targeted Radiotherapy Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Radioactive Iodine Therapeutic Drugs
  • Table 3. Key Players of Radioactive Antibody Therapeutic Drugs
  • Table 4. Key Players of Others
  • Table 5. Global Targeted Radiotherapy Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Targeted Radiotherapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Targeted Radiotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Targeted Radiotherapy Drug Market Share by Region (2018-2023)
  • Table 9. Global Targeted Radiotherapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Targeted Radiotherapy Drug Market Share by Region (2024-2029)
  • Table 11. Targeted Radiotherapy Drug Market Trends
  • Table 12. Targeted Radiotherapy Drug Market Drivers
  • Table 13. Targeted Radiotherapy Drug Market Challenges
  • Table 14. Targeted Radiotherapy Drug Market Restraints
  • Table 15. Global Targeted Radiotherapy Drug Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Targeted Radiotherapy Drug Revenue Share by Players (2018-2023)
  • Table 17. Global Top Targeted Radiotherapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2022)
  • Table 18. Global Targeted Radiotherapy Drug Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Targeted Radiotherapy Drug Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Targeted Radiotherapy Drug, Headquarters and Area Served
  • Table 21. Global Key Players of Targeted Radiotherapy Drug, Product and Application
  • Table 22. Global Key Players of Targeted Radiotherapy Drug, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2018-2023)
  • Table 26. Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2024-2029)
  • Table 28. Global Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Targeted Radiotherapy Drug Revenue Share by Application (2018-2023)
  • Table 30. Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Targeted Radiotherapy Drug Revenue Share by Application (2024-2029)
  • Table 32. North America Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Targeted Radiotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Targeted Radiotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Targeted Radiotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Targeted Radiotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Targeted Radiotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Targeted Radiotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Targeted Radiotherapy Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Targeted Radiotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Targeted Radiotherapy Drug Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Novartis Company Details
  • Table 65. Novartis Business Overview
  • Table 66. Novartis Targeted Radiotherapy Drug Product
  • Table 67. Novartis Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 68. Novartis Recent Developments
  • Table 69. Bayer Company Details
  • Table 70. Bayer Business Overview
  • Table 71. Bayer Targeted Radiotherapy Drug Product
  • Table 72. Bayer Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 73. Bayer Recent Developments
  • Table 74. Endocyte Company Details
  • Table 75. Endocyte Business Overview
  • Table 76. Endocyte Targeted Radiotherapy Drug Product
  • Table 77. Endocyte Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 78. Endocyte Recent Developments
  • Table 79. Progenics Pharmaceuticals Company Details
  • Table 80. Progenics Pharmaceuticals Business Overview
  • Table 81. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product
  • Table 82. Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 83. Progenics Pharmaceuticals Recent Developments
  • Table 84. Jubilant Radiopharma Company Details
  • Table 85. Jubilant Radiopharma Business Overview
  • Table 86. Jubilant Radiopharma Targeted Radiotherapy Drug Product
  • Table 87. Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 88. Jubilant Radiopharma Recent Developments
  • Table 89. Curium Company Details
  • Table 90. Curium Business Overview
  • Table 91. Curium Targeted Radiotherapy Drug Product
  • Table 92. Curium Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 93. Curium Recent Developments
  • Table 94. Fermi Energia Company Details
  • Table 95. Fermi Energia Business Overview
  • Table 96. Fermi Energia Targeted Radiotherapy Drug Product
  • Table 97. Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 98. Fermi Energia Recent Developments
  • Table 99. Nucleus RadioPharma Company Details
  • Table 100. Nucleus RadioPharma Business Overview
  • Table 101. Nucleus RadioPharma Targeted Radiotherapy Drug Product
  • Table 102. Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2018-2023) & (US$ Million)
  • Table 103. Nucleus RadioPharma Recent Developments
  • Table 104. Research Programs/Design for This Report
  • Table 105. Key Data Information from Secondary Sources
  • Table 106. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Targeted Radiotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Targeted Radiotherapy Drug Market Share by Type: 2022 VS 2029
  • Figure 3. Radioactive Iodine Therapeutic Drugs Features
  • Figure 4. Radioactive Antibody Therapeutic Drugs Features
  • Figure 5. Others Features
  • Figure 6. Global Targeted Radiotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Targeted Radiotherapy Drug Market Share by Application: 2022 VS 2029
  • Figure 8. General Hospital Case Studies
  • Figure 9. Specialty Hospital Case Studies
  • Figure 10. Targeted Radiotherapy Drug Report Years Considered
  • Figure 11. Global Targeted Radiotherapy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 12. Global Targeted Radiotherapy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Targeted Radiotherapy Drug Market Share by Region: 2022 VS 2029
  • Figure 14. Global Targeted Radiotherapy Drug Market Share by Players in 2022
  • Figure 15. Global Top Targeted Radiotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2022)
  • Figure 16. The Top 10 and 5 Players Market Share by Targeted Radiotherapy Drug Revenue in 2022
  • Figure 17. North America Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 18. North America Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • Figure 19. North America Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • Figure 20. North America Targeted Radiotherapy Drug Market Share by Country (2018-2029)
  • Figure 21. United States Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. Canada Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Europe Targeted Radiotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
  • Figure 24. Europe Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • Figure 25. Europe Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • Figure 26. Europe Targeted Radiotherapy Drug Market Share by Country (2018-2029)
  • Figure 27. Germany Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. France Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. U.K. Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Italy Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Russia Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Nordic Countries Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. China Targeted Radiotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
  • Figure 34. China Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • Figure 35. China Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • Figure 36. Asia Targeted Radiotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. Asia Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • Figure 38. Asia Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • Figure 39. Asia Targeted Radiotherapy Drug Market Share by Region (2018-2029)
  • Figure 40. Japan Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. South Korea Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. China Taiwan Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. Southeast Asia Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. India Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Australia Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • Figure 48. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Share by Country (2018-2029)
  • Figure 50. Brazil Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Mexico Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Turkey Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Saudi Arabia Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Israel Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. GCC Countries Targeted Radiotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Novartis Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 57. Bayer Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 58. Endocyte Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 59. Progenics Pharmaceuticals Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 60. Jubilant Radiopharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 61. Curium Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 62. Fermi Energia Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 63. Nucleus RadioPharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2018-2023)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed
目次

This research report focuses on the Targeted Radiotherapy Drug Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Targeted Radiotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Radioactive Iodine Therapeutic Drugs
    • 1.2.3 Radioactive Antibody Therapeutic Drugs
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Targeted Radiotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 General Hospital
    • 1.3.3 Specialty Hospital
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Targeted Radiotherapy Drug Market Perspective (2018-2029)
  • 2.2 Global Targeted Radiotherapy Drug Growth Trends by Region
    • 2.2.1 Targeted Radiotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Targeted Radiotherapy Drug Historic Market Size by Region (2018-2023)
    • 2.2.3 Targeted Radiotherapy Drug Forecasted Market Size by Region (2024-2029)
  • 2.3 Targeted Radiotherapy Drug Market Dynamics
    • 2.3.1 Targeted Radiotherapy Drug Industry Trends
    • 2.3.2 Targeted Radiotherapy Drug Market Drivers
    • 2.3.3 Targeted Radiotherapy Drug Market Challenges
    • 2.3.4 Targeted Radiotherapy Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Targeted Radiotherapy Drug by Players
    • 3.1.1 Global Targeted Radiotherapy Drug Revenue by Players (2018-2023)
    • 3.1.2 Global Targeted Radiotherapy Drug Revenue Market Share by Players (2018-2023)
  • 3.2 Global Targeted Radiotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Targeted Radiotherapy Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Targeted Radiotherapy Drug Market Concentration Ratio
    • 3.4.1 Global Targeted Radiotherapy Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Targeted Radiotherapy Drug Revenue in 2022
  • 3.5 Global Key Players of Targeted Radiotherapy Drug Head office and Area Served
  • 3.6 Global Key Players of Targeted Radiotherapy Drug, Product and Application
  • 3.7 Global Key Players of Targeted Radiotherapy Drug, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Radiotherapy Drug Breakdown Data by Type

  • 4.1 Global Targeted Radiotherapy Drug Historic Market Size by Type (2018-2023)
  • 4.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2024-2029)

5 Targeted Radiotherapy Drug Breakdown Data by Application

  • 5.1 Global Targeted Radiotherapy Drug Historic Market Size by Application (2018-2023)
  • 5.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Targeted Radiotherapy Drug Market Size (2018-2029)
  • 6.2 North America Targeted Radiotherapy Drug Market Size by Type
    • 6.2.1 North America Targeted Radiotherapy Drug Market Size by Type (2018-2023)
    • 6.2.2 North America Targeted Radiotherapy Drug Market Size by Type (2024-2029)
    • 6.2.3 North America Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • 6.3 North America Targeted Radiotherapy Drug Market Size by Application
    • 6.3.1 North America Targeted Radiotherapy Drug Market Size by Application (2018-2023)
    • 6.3.2 North America Targeted Radiotherapy Drug Market Size by Application (2024-2029)
    • 6.3.3 North America Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • 6.4 North America Targeted Radiotherapy Drug Market Size by Country
    • 6.4.1 North America Targeted Radiotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Targeted Radiotherapy Drug Market Size by Country (2018-2023)
    • 6.4.3 North America Targeted Radiotherapy Drug Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Targeted Radiotherapy Drug Market Size (2018-2029)
  • 7.2 Europe Targeted Radiotherapy Drug Market Size by Type
    • 7.2.1 Europe Targeted Radiotherapy Drug Market Size by Type (2018-2023)
    • 7.2.2 Europe Targeted Radiotherapy Drug Market Size by Type (2024-2029)
    • 7.2.3 Europe Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • 7.3 Europe Targeted Radiotherapy Drug Market Size by Application
    • 7.3.1 Europe Targeted Radiotherapy Drug Market Size by Application (2018-2023)
    • 7.3.2 Europe Targeted Radiotherapy Drug Market Size by Application (2024-2029)
    • 7.3.3 Europe Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • 7.4 Europe Targeted Radiotherapy Drug Market Size by Country
    • 7.4.1 Europe Targeted Radiotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Targeted Radiotherapy Drug Market Size by Country (2018-2023)
    • 7.4.3 Europe Targeted Radiotherapy Drug Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Targeted Radiotherapy Drug Market Size (2018-2029)
  • 8.2 China Targeted Radiotherapy Drug Market Size by Type
    • 8.2.1 China Targeted Radiotherapy Drug Market Size by Type (2018-2023)
    • 8.2.2 China Targeted Radiotherapy Drug Market Size by Type (2024-2029)
    • 8.2.3 China Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • 8.3 China Targeted Radiotherapy Drug Market Size by Application
    • 8.3.1 China Targeted Radiotherapy Drug Market Size by Application (2018-2023)
    • 8.3.2 China Targeted Radiotherapy Drug Market Size by Application (2024-2029)
    • 8.3.3 China Targeted Radiotherapy Drug Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Targeted Radiotherapy Drug Market Size (2018-2029)
  • 9.2 Asia Targeted Radiotherapy Drug Market Size by Type
    • 9.2.1 Asia Targeted Radiotherapy Drug Market Size by Type (2018-2023)
    • 9.2.2 Asia Targeted Radiotherapy Drug Market Size by Type (2024-2029)
    • 9.2.3 Asia Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • 9.3 Asia Targeted Radiotherapy Drug Market Size by Application
    • 9.3.1 Asia Targeted Radiotherapy Drug Market Size by Application (2018-2023)
    • 9.3.2 Asia Targeted Radiotherapy Drug Market Size by Application (2024-2029)
    • 9.3.3 Asia Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • 9.4 Asia Targeted Radiotherapy Drug Market Size by Region
    • 9.4.1 Asia Targeted Radiotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Targeted Radiotherapy Drug Market Size by Region (2018-2023)
    • 9.4.3 Asia Targeted Radiotherapy Drug Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Targeted Radiotherapy Drug Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Targeted Radiotherapy Drug Introduction
    • 11.1.4 Novartis Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.1.5 Novartis Recent Developments
  • 11.2 Bayer
    • 11.2.1 Bayer Company Details
    • 11.2.2 Bayer Business Overview
    • 11.2.3 Bayer Targeted Radiotherapy Drug Introduction
    • 11.2.4 Bayer Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.2.5 Bayer Recent Developments
  • 11.3 Endocyte
    • 11.3.1 Endocyte Company Details
    • 11.3.2 Endocyte Business Overview
    • 11.3.3 Endocyte Targeted Radiotherapy Drug Introduction
    • 11.3.4 Endocyte Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.3.5 Endocyte Recent Developments
  • 11.4 Progenics Pharmaceuticals
    • 11.4.1 Progenics Pharmaceuticals Company Details
    • 11.4.2 Progenics Pharmaceuticals Business Overview
    • 11.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Introduction
    • 11.4.4 Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.4.5 Progenics Pharmaceuticals Recent Developments
  • 11.5 Jubilant Radiopharma
    • 11.5.1 Jubilant Radiopharma Company Details
    • 11.5.2 Jubilant Radiopharma Business Overview
    • 11.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Introduction
    • 11.5.4 Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.5.5 Jubilant Radiopharma Recent Developments
  • 11.6 Curium
    • 11.6.1 Curium Company Details
    • 11.6.2 Curium Business Overview
    • 11.6.3 Curium Targeted Radiotherapy Drug Introduction
    • 11.6.4 Curium Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.6.5 Curium Recent Developments
  • 11.7 Fermi Energia
    • 11.7.1 Fermi Energia Company Details
    • 11.7.2 Fermi Energia Business Overview
    • 11.7.3 Fermi Energia Targeted Radiotherapy Drug Introduction
    • 11.7.4 Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.7.5 Fermi Energia Recent Developments
  • 11.8 Nucleus RadioPharma
    • 11.8.1 Nucleus RadioPharma Company Details
    • 11.8.2 Nucleus RadioPharma Business Overview
    • 11.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Introduction
    • 11.8.4 Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2018-2023)
    • 11.8.5 Nucleus RadioPharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details